Biomaterials Market Research Report– Global Forecast till 2023

Biomaterials Market Research Report– Global Forecast till 2023

ID: MRFR/CnM/1489-HCR | November, 2019 | Region: Global | 100 pages | Half-Cooked Research Reports

Global Biomaterials Market Information: By Type (Metallic, Ceramics, Polymeric, Natural Biomaterials) Application (Joint Replacements, Ophthalmology, Cardiovascular, Wound Healing, Plastic Surgery, Neurological Conditions, And Others) – Forecast till 2023


Market Scenario



Biomaterials Market size is anticipated to surpass of CAGR 12% by 2023, as reported in the latest study by Market Research Future.


Biomaterials are material of natural or synthetic origin and can be used as implants to substitute any damaged organ or tissue to improve its functionality. The global biomaterials market is fueled by factors such as rise in prevalence of cardiovascular diseases, growing demand for implantable devices, increasing wound healing therapies, rising geriatric population, superior properties of biomaterials, increasing awareness of regenerative medicine, increasing orthopedic disorders, and increasing funds by the government for research purposes.

Furthermore, biomaterials science can be implemented in various advanced medical technologies such as tissue engineering, plastic surgery, drug delivery devices, and other medical implants. Biomaterial applications are finding prominence in the research on biomedical engineering, biomineralization, and biomolecules.

 

Intended Audience



  • Biomaterials manufacturing companies

  • Original equipment manufacturing companies

  • Suppliers and distributors of biomaterials

  • Healthcare service providers

  • Teaching hospitals and academic medical centers (AMCs)

  • Health insurance players

  • Research and consulting firms

  • Medical research institutes

  • Venture capitalists

  • Community Centers


Segmentation


The global biomaterials market is segmented on the basis of type and application.


On the basis of the type, the market is segmented into metallic, ceramics, polymeric, natural biomaterials, and others. The metallic segment is divided into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, silver, gold, and magnesium. The ceramics segment is divided into calcium phosphate, aluminum oxide, zirconia, calcium sulfate, carbon, and glass. The polymeric segment is further divided into polymethylmethacrylate (PMMA), polyethylene, polyester, polyvinyl chloride, silicone rubber, nylon, polyetheretherketone (PEEK), polylactic acid, poly glycolic acid, and poly(lactide-coglycolide), and others. The natural biomaterials is further segmented into hyaluronic acid, collagen, gelatin, fibrin, cellulose, chitin, alginate, and silk


On the basis of the application, the market is classified into cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, neurological disorders, and others


The cardiovascular segment is divided into catheters, stents, implantable cardiac defibrillators, pacemakers, sensors, heart valves, vascular grafts, guidewires, and others.


The orthopedic is divided into joint replacement, viscosupplementation, bioresorbable tissue fixation, spine, fracture fixation devices, and orthobiologics. The joint replacement is further divided into knee replacement, hip replacement, shoulder replacement, and others. The bioresorbable tissue fixation is divided into suture anchors, interference screws, meniscal repair tacks, and meshes. The spine segment is divided into spinal fusion, minimally invasive fusion surgery, and motion preservation. The fracture fixation devices are divided into bone plates, screws, pins, rods, and wires.


The ophthalmology is further divided into contact lens, intraocular lens, functional replacements of ocular tissues, synthetic corneas, and others. The dental segment is further divided into dental implants, dental bone grafts & substitutes, dental membranes, and tissue regeneration materials. The plastic surgery is divided into soft tissue fillers and craniofacial surgery. The wound healing is categorized into wound closure devices, adhesion barriers, surgical hemostats, internal tissue sealants, and hernia meshes. The tissue engineering segment is divided into scaffolds for regenerative medicine, nanomaterials for biosensing, tailoring of inorganic nanoparticles. The neurological disorders segment is divided into shunting systems, cortical neural prosthetics, hydrogel scaffolds for CNS repair, neural stem cell encapsulation


Research Methodology

Biomaterial Market
Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The global biomaterials market consists of countries namely the Americas, Europe, Asia Pacific, and the Middle East.


The Americas dominate the global biomaterials market owing to the increasing healthcare expenditure followed by Europe and Asia Pacific. According to the American Heart Association, the death due to cardiovascular diseases accounted for more than 800,000 in the U.S. Approximately 2,200 Americans die of cardiovascular disease each day. This increase in death ratio in North America is expected to drive the demand for biomaterials based cardiovascular systems. Europe holds the second position in the global biomaterials market owing to the government support for research & development and availability of funds for research.


Asia Pacific is the fastest growing region owing to the increasing obesity, introduction of biomaterials in cancer research, and rising patient awareness and improved lifestyle in growing economies such as India, China, and Brazil are expected to create opportunities in the biomaterials market. Additionally, the region has the highest potential to grow in the forecast period due to the presence of emerging economies such as China and India.


The Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.


Key Players


Some major players in the global biomaterials market include Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Covestro (Germany), Invibio Ltd. (U.K.), Carpenter Technology Corporation (U.S.), Evonik Industries AG (Germany), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Celanese Corporation (U.S.), Wright Medical Technology, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany),  Collagen Matrix (U.S.).

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Biomaterials Market, by Type

6.1 Introduction

6.2 Metallic

6.2.1 Market Estimates & Forecast, 2017 – 2023

6.2.2 Stainless Steel

6.2.2.1 Market Estimates & Forecast, 2017 – 2023

6.2.3 Titanium & Titanium Alloys

6.2.3.1 Market Estimates & Forecast, 2017 – 2023

6.2.4 Cobalt-Chrome Alloys

6.2.4.1 Market Estimates & Forecast, 2017 – 2023

6.2.5 Silver

6.2.5.1 Market Estimates & Forecast, 2017 – 2023

6.2.6 Gold

6.2.6.1 Market Estimates & Forecast, 2017 – 2023

6.2.7 Magnesium

6.2.7.1 Market Estimates & Forecast, 2017 – 2023

6.3 Ceramic

6.3.1 Market Estimates & Forecast, 2017 – 2023

6.3.2 Calcium Phosphate

6.3.2.1 Market Estimates & Forecast, 2017 – 2023

6.3.3 Aluminum Oxide

6.3.3.1 Market Estimates & Forecast, 2017 – 2023

6.3.4 Zirconia

6.3.4.1 Market Estimates & Forecast, 2017 – 2023

6.3.5 Calcium Sulfate

6.3.5.1 Market Estimates & Forecast, 2017 – 2023

6.3.6 Carbon

6.3.6.1 Market Estimates & Forecast, 2017 – 2023

6.3.7 Glass

6.3.7.1 Market Estimates & Forecast, 2017 – 2023

6.4 Polymeric

6.4.1 Market Estimates & Forecast, 2017 – 2023

6.4.2 Polymethylmethacrylate (PMMA)

6.4.2.1 Market Estimates & Forecast, 2017 – 2023

6.4.3 Polyethylene

6.4.3.1 Market Estimates & Forecast, 2017 – 2023

6.4.4 Polyester

6.4.4.1 Market Estimates & Forecast, 2017 – 2023

6.4.5 Polyvinyl Chloride

6.4.5.1 Market Estimates & Forecast, 2017 – 2023

6.4.6 Silicone Rubber

6.4.6.1 Market Estimates & Forecast, 2017 – 2023

6.4.7 Nylon

6.4.7.1 Market Estimates & Forecast, 2017 – 2023

6.4.8 Polyetheretherketone (PEEK)

6.4.8.1 Market Estimates & Forecast, 2017 – 2023

6.4.9 Polylactic Acid

6.4.9.1 Market Estimates & Forecast, 2017 – 2023

6.4.10 Others

6.5 Natural Biomaterials

6.5.1 Market Estimates & Forecast, 2017 – 2023

6.5.2 Hyaluronic Acid

6.5.2.1 Market Estimates & Forecast, 2017 – 2023

6.5.3 Collagen

6.5.3.1 Market Estimates & Forecast, 2017 – 2023

6.5.4 Gelatin

6.5.4.1 Market Estimates & Forecast, 2017 – 2023

6.5.5 Fibrin

6.5.5.1 Market Estimates & Forecast, 2017 – 2023

6.5.6 Cellulose

6.5.6.1 Market Estimates & Forecast, 2017 – 2023

6.5.7 Chitin

6.5.7.1 Market Estimates & Forecast, 2017 – 2023

6.5.8 Alginate

6.5.8.1 Market Estimates & Forecast, 2017 – 2023

6.5.8 Silk

6.5.8.1 Market Estimates & Forecast, 2017 – 2023

6.6 Others

Chapter 7. Global Biomaterials Market, by Application

7.1 Introduction

7.2 Cardiovascular

7.2.1 Market Estimates & Forecast, 2017 – 2023

7.2.2 Catheters

7.2.2.1 Market Estimates & Forecast, 2017 – 2023

7.2.3 Stents

7.2.3.1 Market Estimates & Forecast, 2017 – 2023

7.2.4 Implantable Cardiac Defibrillators

7.2.4.1 Market Estimates & Forecast, 2017 – 2023

7.2.5 Pacemakers

7.2.5.1 Market Estimates & Forecast, 2017 – 2023

7.2.6 Sensors

7.2.6.1 Market Estimates & Forecast, 2017 – 2023

7.2.7 Heart Valves

7.2.7.1 Market Estimates & Forecast, 2017 – 2023

7.2.8 Vascular Grafts

7.2.8.1 Market Estimates & Forecast, 2017 – 2023

7.2.9 Guidewires

7.2.9.1 Market Estimates & Forecast, 2017 – 2023

7.2.10 Others

7.3 Orthopedic

7.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.2 Joint Replacement

7.3.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.2 Knee Replacement

7.3.2.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.3 Hip Replacement

7.3.2.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.4 Shoulder Replacement

7.3.2.4.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.5 Others

7.3.3 Viscosupplementation

7.3.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.4 Bioresorbable Tissue Fixation

7.3.4.1 Market Estimates & Forecast, 2017 – 2023

7.3.4.2 Suture Anchors

7.3.4.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.4.3 Interference Screws

7.3.4.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.4.4 Meniscal Repair Tacks

7.3.4.4.1 Market Estimates & Forecast, 2017 – 2023

7.3.4.5 Meshes

7.3.4.5.1 Market Estimates & Forecast, 2017 – 2023

7.3.5 Spine

7.3.5.1 Market Estimates & Forecast, 2017 – 2023

7.3.5.2 Spinal Fusion

7.3.5.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.5.3 Minimally Invasive Fusion Surgery

7.3.5.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.5.4 Motion Preservation

7.3.5.4.1 Market Estimates & Forecast, 2017 – 2023

7.3.6 Fracture Fixation Devices

7.3.6.1 Market Estimates & Forecast, 2017 – 2023

7.3.6.2 Bone Plates

7.3.6.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.6.3 Screws

7.3.6.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.6.4 Pins

7.3.6.4.1 Market Estimates & Forecast, 2017 – 2023

7.3.6.5 Rods

7.3.6.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.6.6 Wires

7.3.6.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.7 Orthobiologics

7.3.7.1 Market Estimates & Forecast, 2017 – 2023

7.4 Ophthalmology

7.4.1 Market Estimates & Forecast, 2017 – 2023

7.4.2 Contact Lens

7.4.2.1 Market Estimates & Forecast, 2017 – 2023

7.4.3 Intraocular Lens

7.4.3.1 Market Estimates & Forecast, 2017 – 2023

7.4.4 Functional Replacements of Ocular Tissues

7.4.4.1 Market Estimates & Forecast, 2017 – 2023

7.4.5 Synthetic Corneas

7.4.5.1 Market Estimates & Forecast, 2017 – 2023

7.4.6 Others

7.5 Dental

7.5.1 Market Estimates & Forecast, 2017 – 2023

7.5.2 Dental Implants

7.5.2.1 Market Estimates & Forecast, 2017 – 2023

7.5.3 Dental Bone Grafts & Substitutes

7.5.3.1 Market Estimates & Forecast, 2017 – 2023

7.5.4 Dental Membranes

7.5.4.1 Market Estimates & Forecast, 2017 – 2023

7.5.5 Tissue Regeneration Materials

7.5.5.1 Market Estimates & Forecast, 2017 – 2023

7.6 Plastic Surgery

7.6.1 Market Estimates & Forecast, 2017 – 2023

7.6.2 Soft Tissue Fillers

7.6.2.1 Market Estimates & Forecast, 2017 – 2023

7.6.3 Craniofacial Surgery

7.6.3.1 Market Estimates & Forecast, 2017 – 2023

7.7 Wound Healing

7.7.1 Market Estimates & Forecast, 2017 – 2023

7.7.2 Wound Closure Devices

7.7.2.1 Market Estimates & Forecast, 2017 – 2023

7.7.3 Adhesion Barriers

7.7.3.1 Market Estimates & Forecast, 2017 – 2023

7.7.4 Surgical Hemostats

7.7.4.1 Market Estimates & Forecast, 2017 – 2023

7.7.5 Internal Tissue Sealants

7.7.5.1 Market Estimates & Forecast, 2017 – 2023

7.7.6 Hernia Meshes

7.7.6.1 Market Estimates & Forecast, 2017 – 2023

7.8 Tissue Engineering

7.8.1 Market Estimates & Forecast, 2017 – 2023

7.8.2 Scaffolds for Regenerative Medicine

7.8.2.1 Market Estimates & Forecast, 2017 – 2023

7.8.3 Nanomaterials for Biosensing

7.8.3.1 Market Estimates & Forecast, 2017 – 2023

7.8.4 Tailoring of Inorganic Nanoparticles

7.8.4.1 Market Estimates & Forecast, 2017 – 2023

7.9 Neurological Disorders

7.9.1 Market Estimates & Forecast, 2017 – 2023

7.9.2 Shunting Systems

7.9.2.1 Market Estimates & Forecast, 2017 – 2023

7.9.3 Cortical Neural Prosthetics

7.9.3.1 Market Estimates & Forecast, 2017 – 2023

7.9.4 Hydrogel Scaffolds for CNS Repair

7.9.4.1 Market Estimates & Forecast, 2017 – 2023

7.9.5 Neural Stem Cell Encapsulation

7.9.5.1 Market Estimates & Forecast, 2017 – 2023

7.10 Others

Chapter .8 Global Biomaterials Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 U.K

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia Pacific

8.5 The Middle East & Africa

8.5.1 United Arab Emirates

8.5.2 Saudi Arabia

8.5.3 Oman

8.5.4 Kuwait

8.5.5 Qatar

8.5.6 Rest of the Middle East & Africa

Chapter 9 Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

9.3.1 Key Developments

Chapter 10 Company Profiles

10.1 Royal DSM

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials

10.1.4 SWOT Analysis

10.2 BASF SE

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Corbion N.V.

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Covestro

10.4.1 Company Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Invibio Ltd.

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.6 Carpenter Technology Corporation

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.7 Evonik Industries AG

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Berkeley Advanced Biomaterials, Inc.

10.8.1 Company Overview

10.8.2 Product/Business Segment Overview

10.8.3 Financial Overview

10.8.4 Key Development

10.8.5 SWOT Analysis

10.9 CAM Bioceramics BV

10.9.1 Company Overview

10.9.2 Product Overview

10.9.3 Financial overview

10.9.4 Key Developments

10.10 Celanese Corporation

10.10.1 Company Overview

10.10.2 Product Overview

10.10.3 Financial overview

10.10.4 Key Developments

10.11 Others

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View Point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Prediction of Pharmaceutical industry

Chapter 12 Appendix

LIST OF TABLES

Table 1 Biomaterials Industry Synopsis, 2017 – 2023

Table 2 Biomaterials Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3 Biomaterials Market by Region, 2017 – 2023, (USD Million)

Table 4 Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 5 Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 6 Biomaterials Market by End Users, 2017 – 2023, (USD Million)

Table 7 North America Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 8 North America Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 9 US Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 10 US Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 11 Canada Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 12 Canada Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 13 South America Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 14 South America Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 15 Europe Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 16 Europe Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 17 Western Europe Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 18 Western Europe Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 19 Eastern Europe Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 20 Eastern Europe Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 21 Asia Pacific Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 22 Asia Pacific Biomaterials Market by Application, 2017 – 2023, (USD Million)

Table 23 Middle East & Africa Biomaterials Market by Type, 2017 – 2023, (USD Million)

Table 24 Middle East & Africa Biomaterials Market by Application, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Biomaterials Market

Figure 3 Segmentation Market Dynamics for Biomaterials Market

Figure 4 Global Biomaterials Market Share, by Type 2016

Figure 5 Global Biomaterials Market Share, by Application 2016

Figure 6 Global Biomaterials Market Share, by Region, 2016

Figure 7 Americas Biomaterials Market Share, by Country, 2016

Figure 8 Europe Biomaterials Market Share, by Country, 2016

Figure 9 Asia Pacific Biomaterials Market Share, by Country, 2016

Figure 10 Middle East & Africa Biomaterials Market Share, by Country, 2016

Figure 11 Global Biomaterials Market: Company Share Analysis, 2016 (%)

Figure 12 Royal DSM: Key Financials

Figure 13 Royal DSM: Segmental Revenue

Figure 14 Royal DSM: Geographical Revenue

Figure 15 BASF SE: Key Financials

Figure 16 BASF SE: Segmental Revenue

Figure 17 BASF SE: Geographical Revenue

Figure 18 Corbion N.V.: Key Financials

Figure 19 Corbion N.V.: Segmental Revenue

Figure 20 Corbion N.V.: Geographical Revenue

Figure 21 Covestro: Key Financials

Figure 22 Covestro: Segmental Revenue

Figure 23 Covestro: Geographical Revenue

Figure 24 Invibio Ltd.: Key Financials

Figure 25 Invibio Ltd.: Segmental Revenue

Figure 26 Invibio Ltd.: Geographical Revenue

Figure 27 Carpenter Technology Corporation: Key Financials

Figure 28 Carpenter Technology Corporation: Segmental Revenue

Figure 29 Carpenter Technology Corporation: Geographical Revenue

Figure 30 Evonik Industries AG: Key Financials

Figure 31 Evonik Industries AG: Segmental Revenue

Figure 32 Evonik Industries AG: Geographical Revenue

Figure 33 Berkeley Advanced Biomaterials, Inc.: Key Financials

Figure 34 Berkeley Advanced Biomaterials, Inc.: Segmental Revenue

Figure 35 Berkeley Advanced Biomaterials, Inc.: Geographical Revenue

Figure 36 CAM Bioceramics BV: Key Financials

Figure 37 CAM Bioceramics BV: Segmental Revenue

Figure 38 CAM Bioceramics BV: Geographical Revenue